CIK: 1190429 - Address: C/O Acelrx Pharmaceuticals, Inc., 25821 Industrial Blvd., Suite 400, Hayward, CA 94545
13 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11541619131510
P%wins804060100807573

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/12/19 16:22
11/12/19
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP451.7802511244D
8/26/19 16:52
8/23/19
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP.m332.190157219D
3/12/19 14:15
3/12/19
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP572.9901910200D
11/15/18 18:35
11/15/18
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP582.8202113181D
8/8/18 16:36
8/7/18
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP152.84053160D
6/5/18 17:52
6/1/18
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP.m173.35053155D
11/15/17 07:01
11/14/17
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP571.9003025150D
8/24/17 17:54
8/22/17
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP.m153.02054120D
5/12/16 18:40
5/10/16
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP.m473.1511515115D-684-36-82-16-4-355417-10
5/7/15 17:35
5/7/15
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP1253.1324067100D-49-71-54-53-19-33-30-245-33752460
6/10/13 14:57
6/6/13
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP818.105102060D8317413877483055101127213-1
12/2/11 15:54
12/1/11
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP282.790102550D-39-61510-2-6-341335
11/16/11 16:57
11/14/11
ACRXAcelrx Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsEdwards Mark GCADP1162.90040New40D-27-16-30270-2-532525

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact